HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Second transplantation with CD34+ blood cells from an HLA-mismatched related donor after engraftment failure of transplanted cord blood cells.

Abstract
Unrelated cord blood transplantation (CBT) has been worldwide for bone marrow reconstitution. CBT is associated with a high frequency of engraftment failure and rejection due to a small dose of graft cells. In cases of engraftment failure or rejection following unrelated CBT, retransplantation from the original donors is impossible. We report a successful transplantation with CD34+ blood cells selected from a 2-loci HLA-mismatched mother to a child with acute monocytic leukemia after engraftment failure of the primary CBT. Selected CD34+ blood cell transplantation is a useful approach for retransplantation in the setting of engraftment failure.
AuthorsH Ohta, J Y Kim, A Sawada, S Tokimasa, H Fujisaki, Y Matsuda, Y Osugi, J Hara
JournalInternational journal of hematology (Int J Hematol) Vol. 74 Issue 3 Pg. 338-41 (Oct 2001) ISSN: 0925-5710 [Print] Japan
PMID11721973 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antigens, CD34
Topics
  • Adult
  • Antigens, CD34 (analysis)
  • Blood Cells (cytology, immunology, transplantation)
  • Disease-Free Survival
  • Female
  • Fetal Blood (cytology)
  • Graft Survival
  • Hematopoietic Stem Cell Transplantation
  • Histocompatibility
  • Histocompatibility Testing
  • Humans
  • Infant, Newborn
  • Leukemia, Monocytic, Acute (therapy)
  • Male

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: